• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂质过氧化的一种新标志物:非酒精性脂肪性肝炎患者的血清对氧磷酶活性

A new marker for lipid peroxidation: serum paraoxonase activity in non-alcoholic steatohepatitis.

作者信息

Başkol Mevlüt, Başkol Gülden, Deniz Kemal, Ozbakir Omer, Yücesoy Mehmet

机构信息

Department of Gastroenterology, School of Medicine, Erciyes University, Kayseri, Turkey.

出版信息

Turk J Gastroenterol. 2005 Sep;16(3):119-23.

PMID:16245219
Abstract

BACKGROUND/AIMS: Relationship between hepatic antioxidant paraoxonase 1 (PON1) activity, lipid peroxidation and liver injury was investigated in patients with non-alcoholic steatohepatitis.

METHODS

A total of 23 patients with non-alcoholic steatohepatitis (15 males, 8 females; mean age: 40.30+/-7.67 yrs) and 23 healthy controls (14 males, 9 females; mean age: 39.70+/- 8.78 yrs) were enrolled in the study. Serum paraoxonase 1 activity and levels of a well-known lipid peroxidation marker, serum malondialdehyde, were determined.

RESULTS

Serum paraoxonase 1 activity decreased significantly in non-alcoholic steatohepatitis compared to the control group (p<0.01). Serum malondialdehyde levels were significantly higher in patients with non-alcoholic steatohepatitis as compared with the control group (p<0.05). No statistically significant correlations were found between serum paraoxonase 1 activities and the grade-stage of non-alcoholic steatohepatitis, serum lipid levels or serum malondialdehyde levels (p>0.05).

CONCLUSIONS

Increased lipid peroxidation may be either a cause or a result of liver injury in patients with non-alcoholic steatohepatitis. Although serum paraoxonase 1 activity does not reflect the degree of liver damage in non-alcoholic steatohepatitis, reduced paraoxonase 1 activity, especially in the presence of mild disease, could be interpreted as a biochemical marker of the lipid peroxidation.

摘要

背景/目的:研究非酒精性脂肪性肝炎患者肝脏抗氧化对氧磷酶1(PON1)活性、脂质过氧化与肝损伤之间的关系。

方法

本研究共纳入23例非酒精性脂肪性肝炎患者(男性15例,女性8例;平均年龄:40.30±7.67岁)和23例健康对照者(男性14例,女性9例;平均年龄:39.70±8.78岁)。测定血清对氧磷酶1活性以及一种著名的脂质过氧化标志物血清丙二醛的水平。

结果

与对照组相比,非酒精性脂肪性肝炎患者血清对氧磷酶1活性显著降低(p<0.01)。与对照组相比,非酒精性脂肪性肝炎患者血清丙二醛水平显著升高(p<0.05)。血清对氧磷酶1活性与非酒精性脂肪性肝炎的分级分期、血脂水平或血清丙二醛水平之间未发现统计学显著相关性(p>0.05)。

结论

脂质过氧化增加可能是非酒精性脂肪性肝炎患者肝损伤的原因或结果。虽然血清对氧磷酶1活性不能反映非酒精性脂肪性肝炎患者的肝损伤程度,但对氧磷酶1活性降低,尤其是在轻度疾病存在时,可被解释为脂质过氧化的生化标志物。

相似文献

1
A new marker for lipid peroxidation: serum paraoxonase activity in non-alcoholic steatohepatitis.脂质过氧化的一种新标志物:非酒精性脂肪性肝炎患者的血清对氧磷酶活性
Turk J Gastroenterol. 2005 Sep;16(3):119-23.
2
Paraoxonase-1 activity, malondialdehyde and glutathione peroxidase in non-alcoholic fatty liver disease and the effect of atorvastatin.非酒精性脂肪性肝病中对氧磷酶-1活性、丙二醛和谷胱甘肽过氧化物酶以及阿托伐他汀的作用
Arab J Gastroenterol. 2011 Jun;12(2):80-5. doi: 10.1016/j.ajg.2011.04.008. Epub 2011 May 18.
3
Association of serum paraoxonase activity with insulin sensitivity and oxidative stress in hyperthyroid and TSH-suppressed nodular goitre patients.甲状腺功能亢进和促甲状腺激素抑制性结节性甲状腺肿患者血清对氧磷酶活性与胰岛素敏感性及氧化应激的关系
Clin Endocrinol (Oxf). 2004 Oct;61(4):515-21. doi: 10.1111/j.1365-2265.2004.02123.x.
4
Serum paraoxonase 1 activity and malondialdehyde levels in patients with ulcerative colitis.溃疡性结肠炎患者血清对氧磷酶1活性及丙二醛水平
Cell Biochem Funct. 2006 May-Jun;24(3):283-6. doi: 10.1002/cbf.1224.
5
Assessment of paraoxonase 1 activity and malondialdehyde levels in patients with rheumatoid arthritis.类风湿关节炎患者对氧磷酶1活性及丙二醛水平的评估。
Clin Biochem. 2005 Oct;38(10):951-5. doi: 10.1016/j.clinbiochem.2005.06.010.
6
Orlistat increases serum paraoxonase activity in obese patients.奥利司他可提高肥胖患者的血清对氧磷酶活性。
Nutr Metab Cardiovasc Dis. 2007 May;17(4):268-73. doi: 10.1016/j.numecd.2006.03.004. Epub 2006 Jul 10.
7
Marked elevation of serum mitochondrion-derived markers in mild models of non-alcoholic steatohepatitis in rats.大鼠非酒精性脂肪性肝炎轻度模型中血清线粒体衍生标志物显著升高。
J Gastroenterol Hepatol. 2009 Feb;24(2):270-7. doi: 10.1111/j.1440-1746.2008.05597.x. Epub 2008 Sep 24.
8
Levels of serum hyaluronic acid, TNF-alpha and IL-8 in patients with nonalcoholic steatohepatitis.非酒精性脂肪性肝炎患者血清透明质酸、肿瘤坏死因子-α和白细胞介素-8水平
Hepatogastroenterology. 2005 Sep-Oct;52(65):1549-53.
9
Levels of paraoxonase and arylesterase activities and malondialdehyde in workers exposed to ionizing radiation.遭受电离辐射的工人的对氧磷酶和芳基酯酶活性及丙二醛水平
Cell Biochem Funct. 2003 Dec;21(4):371-5. doi: 10.1002/cbf.1042.
10
Serum levels of acute phase proteins in patients with nonalcoholic steatohepatitis.非酒精性脂肪性肝炎患者血清急性期蛋白水平
Turk J Gastroenterol. 2003 Mar;14(1):12-7.

引用本文的文献

1
From NAFLD to MASLD: Meta-analysis and systematic review of NAFLD patients in Turkiye in terms of metabolic profile and MASLD potential.从非酒精性脂肪性肝病到代谢功能障碍相关脂肪性肝病:土耳其非酒精性脂肪性肝病患者代谢特征及代谢功能障碍相关脂肪性肝病潜在风险的荟萃分析与系统评价
Hepatol Forum. 2024 Jul 2;5(3):126-138. doi: 10.14744/hf.2023.2023.0042. eCollection 2024.
2
Serum Arylesterase, Paraoxonase, and Lactonase Activities and Paraoxonase-1 Concentrations in Morbidly Obese Patients and Their Relationship with Non-Alcoholic Steatohepatitis.病态肥胖患者的血清芳基酯酶、对氧磷酶和内酯酶活性及对氧磷酶-1浓度及其与非酒精性脂肪性肝炎的关系
Antioxidants (Basel). 2023 Nov 23;12(12):2038. doi: 10.3390/antiox12122038.
3
Advances in Noninvasive Biomarkers for Nonalcoholic Fatty Liver Disease.
非酒精性脂肪性肝病无创生物标志物的进展
Metabolites. 2023 Oct 29;13(11):1115. doi: 10.3390/metabo13111115.
4
Serum Activities of Paraoxonase 1 (PON1) in Predicting Liver Damage Among Patients Diagnosed With Hepatocellular Carcinoma: A Case-Control Study.对氧磷酶1(PON1)血清活性在预测肝细胞癌患者肝损伤中的作用:一项病例对照研究。
Cureus. 2023 Sep 29;15(9):e46234. doi: 10.7759/cureus.46234. eCollection 2023 Sep.
5
Paraoxonase 1 and Non-Alcoholic Fatty Liver Disease: A Meta-Analysis.对氧磷酶 1 与非酒精性脂肪性肝病:一项荟萃分析。
Molecules. 2021 Apr 16;26(8):2323. doi: 10.3390/molecules26082323.
6
Paraoxonase-1 Serum Concentration and Gene Polymorphisms: Relationship with Non-Alcoholic Fatty Liver Disease.对氧磷酶-1血清浓度与基因多态性:与非酒精性脂肪性肝病的关系
J Clin Med. 2019 Dec 13;8(12):2200. doi: 10.3390/jcm8122200.
7
Serum Basal Paraoxonase 1 Activity as an Additional Liver Function Test for the Evaluation of Patients with Chronic Hepatitis.血清基础对氧磷酶1活性作为评估慢性肝炎患者的一项附加肝功能检测指标。
J Clin Diagn Res. 2015 Nov;9(11):BC12-5. doi: 10.7860/JCDR/2015/15917.6850. Epub 2015 Nov 1.
8
Effect of PON1 gene polymorphisms in Turkish patients with hepatocellular carcinoma.土耳其肝细胞癌患者中对氧磷酶1(PON1)基因多态性的影响。
Meta Gene. 2013 Oct 28;1:93-101. doi: 10.1016/j.mgene.2013.09.007. eCollection 2013 Dec.
9
Noninvasive Diagnosis of NASH and Liver Fibrosis Within the Spectrum of NAFLD.非酒精性脂肪性肝病范围内非酒精性脂肪性肝炎和肝纤维化的无创诊断
Gastroenterol Hepatol (N Y). 2012 Oct;8(10):661-8.
10
OxNASH score correlates with histologic features and severity of nonalcoholic fatty liver disease.OxNASH 评分与非酒精性脂肪性肝病的组织学特征和严重程度相关。
Dig Dis Sci. 2014 Jul;59(7):1617-24. doi: 10.1007/s10620-014-3031-8. Epub 2014 Jan 25.